in the news

Recent Rosacea Blog Posts

The Daily Mail continues its interest in rosacea treatments with an article about an unnamed glaucoma treatment that has been formulated as a gel treatment for the redness of rosacea. Of course we know this treatment as Sansrosa. Other names we have seen over the years include COL-118 and CD07805/47. The active ingredient in the […]

Continue Reading

IPL London Spa Burn Victim Awarded Tens of Thousands in Damages

In 2008 we heard about Charlotte Cripps, a writer for the The Independent was badly burned by an IPL treatment at a London Spa. Today we read a follow up article that tells us that Ms Cripps may be permanently scarred.  Ms Cripps has been awarded a `five-figure sum’ as compensation and is also calling […]

Continue Reading

FDA Approved 35 New Drugs in FY 2011

The FDA announced today that the U.S. Food and Drug Administration approved 35 new medicines in fiscal year 2011. They included “important advances for patients, including: two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus […]

Continue Reading

Dr. Oz: Pineapple + Cottage Cheese, Get Bromelain from your fridge

Are you searching for a natural therapy to quickly relieve your symptoms? Would you be willing to try freshly crushed pineapple and cottage cheese on your face? Give the wild and whacky rosacea treatments that emerge from time to time, pineapple and cheese doesn’t sound too bad ! Ellen Marmur, MD has an article today […]

Continue Reading

Some quick links to items from around the web. 1. Internet Searching leads to greater anxiety for melanoma sufferers Of course everyone is now using the internet to read up on everything health related. You may be headed for some unnecessary anxiety though, so be careful. Internet Use and Anxiety in People with Melanoma and […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.